Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 8/20 | 0.40 |
| ▸ | CA2 | P00918 | 6/20 | 0.40 |
| ▸ | CA4 | P22748 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29406971 | 1.00 | MAOB (0.42) | MAOBSLC1A1FOLH1CA1CA2 | |
| SCHEMBL4938839 | 1.00 | MAOB (0.42) | MAOBSLC1A1FOLH1CA1CA2 | |
| SCHEMBL8059292 | 0.99 | MAOB (0.43) | MAOBSLC1A1FOLH1CA1CA2 | |
| SCHEMBL8068462 | 0.99 | MAOB (0.43) | MAOBSLC1A1FOLH1CA1CA2 | |
| SCHEMBL8068485 | 0.99 | MAOB (0.43) | MAOBSLC1A1FOLH1CA1CA2 | |
| SCHEMBL8059372 | 0.95 | SLC1A1 (0.44) | MAOBSLC1A1FOLH1CA1CA2 | |
| SCHEMBL6443574 | 0.94 | FOLH1 (0.46) | MAOBSLC1A1FOLH1CA1CA2 | |
| SCHEMBL7594884 | 0.93 | SLC1A1 (0.47) | MAOBSLC1A1FOLH1CA1CA2 | |
| SCHEMBL29742385 | 0.93 | MAOB (0.42) | MAOBSLC1A1FOLH1CA1CA2 | |
| SCHEMBL6443585 | 0.91 | MAOB (0.38) | MAOBSLC1A1FOLH1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3325992-B1 | QUANTITATIVE MAGNETIC RESONANCE IMAGING OF THE VASCULATURE | UNIV NORTHEASTERN (US) | 2026-01-28 | — | — | EP | claimed |
| US-20250064988-A1 | MRI-AGENT LOADED PLATELET COMPOSITIONS AND METHODS OF PREPARING AND USING THE SAME | CELLPHIRE, INC. (US) | 2025-02-27 | — | — | US | claimed |
| WO-2023245169-A1 | ANTIMICROBIAL PEPTIDE COMBINATIONS | Vestaron Corporation (US) | 2023-12-21 | — | — | WO | claimed |
| WO-2023220694-A1 | MRI-AGENT LOADED PLATELET COMPOSITIONS AND METHODS OF PREPARING AND USING THE SAME | CELLPHIRE, INC. (US) | 2023-11-16 | — | — | WO | claimed |
| CN-116440315-A | Multi-mode developed gelatin sponge microsphere and preparation method thereof | 海南百迈科医疗科技股份有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-113209304-B | Chelated calcium self-assembled nano particle and preparation method and application thereof | 复旦大学附属金山医院(上海市金山区核化伤害应急救治中心、上海市金山区眼病防治所) | 2023-01-24 | — | — | CN | claimed |
| US-11383008-B2 | Surface-modified polymeric substrates grafted with a properties-imparting compound using clip chemistry | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2022-07-12 | — | — | US | claimed |
| US-11110185-B2 | Combination formulation | GE HEALTHCARE AS (NO) | 2021-09-07 | — | — | US | claimed |
| EP-3474911-B1 | SURFACE-MODIFIED POLYMERIC SUBSTRATES GRAFTED WITH A PROPERTIES-IMPARTING COMPOUND USING CLIP CHEMISTRY | CENTRE NAT RECH SCIENT (FR) | 2020-12-30 | — | — | EP | claimed |
| US-20190247551-A1 | SURFACE-MODIFIED POLYMERIC SUBSTRATES GRAFTED WITH A PROPERTIES-IMPARTING COMPOUND USING CLIP CHEMISTRY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2019-08-15 | — | — | US | claimed |
| EP-1423436-B1 | USE OF HEPARINOID DERIVATIVES FOR TREATING AND DIAGNOSING DISEASES THAT CAN BE TREATED BY HEPARINOIDS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-04-12 | — | — | EP | claimed |
| US-20050175543-A1 | Distinguish between tumor cells and normal cells using novel contrast agents that contain a Magnetic Resonance Imaging (MRI) detectable moiety bound, optionally through a spacer, to a (pseudo)nutrient such as glucose, a natural or unnatural amino acid such as agmatine, or a polyamine such as spermidine | BRACCO IMAGING S.P.A. (IT) | 2005-08-11 | — | — | US | claimed |
| EP-1210359-B1 | A PROCESS FOR THE PREPARATION OF 3-AMINO BILE ACID DERIVATIVES | BRACCO IMAGING SPA (IT) | 2005-05-11 | — | — | EP | claimed |
| US-20050008573-A1 | Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri) | BRACCO IMAGING S.P.A. (IT) | 2005-01-13 | — | — | US | claimed |
| EP-1369134-A1 | New agents for magnetic imaging method | Bracco Imaging S.p.A. (IT) | 2003-12-10 | — | — | EP | claimed |
| US-20030109491-A1 | Use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2003-06-12 | — | — | US | claimed |
| US-20020019549-A1 | Bile acid salts | BRACCO INTERNATIONAL B.V. | 2002-02-14 | — | — | US | claimed |
| EP-0743283-B1 | Recovery of gadolinium and its complexing agents from aqueous solutions containing their complexes | BRACCO IMAGING SPA (IT) | 2001-06-27 | — | — | EP | claimed |
| US-5595714-A | Recovery of gadolinium and its complexing agents from aqueous solutions containing their complexes | DIBRA S.P.A. (IT) | 1997-01-21 | — | — | US | claimed |
| EP-0743283-A2 | Recovery of gadolinium and its complexing agents from aqueous solutions containing their complexes | BRACCO S.p.A. (IT) | 1996-11-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11110185-B2 | Combination formulation | SLC10A1, SLC10A2, RXFP2 | MAOB 590/4885SLC1A1 1841/4885FOLH1 675/4885 |
| US-20030109491-A1 | Use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids | SERPINC1, SSB, ADAMTS13 | MAOB 1626/4885SLC1A1 3253/4885FOLH1 2087/4885 |
| US-20020019549-A1 | Bile acid salts | NR1H4, SLC10A1, SLC10A2 | MAOB 1770/4885SLC1A1 1043/4885FOLH1 909/4885 |
| US-20050175543-A1 | Distinguish between tumor cells and normal cells using novel contrast agents that contain a Magnetic Resonance Imaging (MRI) detectable moiety bound, optionally through a spacer, to a (pseudo)nutrient such as glucose, a natural or unnatural amino acid such as agmatine, or a polyamine such as spermidine | SLC7A5, SLC2A9, SLC2A1 | MAOB 4475/4885SLC1A1 34/4885FOLH1 235/4885 |
| US-20190247551-A1 | SURFACE-MODIFIED POLYMERIC SUBSTRATES GRAFTED WITH A PROPERTIES-IMPARTING COMPOUND USING CLIP CHEMISTRY | CLASP1, MACF1, MICA | MAOB 853/4885SLC1A1 3554/4885FOLH1 1269/4885 |
| US-11383008-B2 | Surface-modified polymeric substrates grafted with a properties-imparting compound using clip chemistry | CLASP1, MACF1, MICA | MAOB 853/4885SLC1A1 3554/4885FOLH1 1269/4885 |
| US-20050008573-A1 | Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri) | CCKAR, SSTR3, SSTR1 | MAOB 3276/4885SLC1A1 200/4885FOLH1 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.